Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients-Reference-Cited by-同舟云学术

Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients

Published:1996-05 Issue:3 Volume:32 Page:163-168
ISSN:0964-1955
Container-title:European Journal of Cancer Part B: Oral Oncology
language:en
Short-container-title:European Journal of Cancer Part B: Oral Oncology

Author:

Vera-Sempere F.J.,Burgos J.S.,Botella M.S.,Cordoba J.,Gobernado M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Nasopharyngeal carcinoma: the Epstein-Barr virus association;Liebowitz;Semin Oncol,1994

2. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2;Fingeroth,1984

3. Epstein-Barr virus replication in oropharyngeal epithelial cells;Sixbey;N Engl J Med,1984

4. Immunoglobulin A-induce shift of Epstein-Barr virus tissue tropism;Sixbey;Science,1992

5. Epstein—Barr virus persistence and virus-associated tumours;Niedobitek;Lancet,1994

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Role of Epstein–Barr Virus in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma: A Scoping Review;Viruses;2022-04-13

2. Design of InnoPrimers-Duplex Real-Time PCR for Detection and Treatment Response Prediction of EBV-Associated Nasopharyngeal Carcinoma Circulating Genetic Biomarker;Diagnostics;2021-09-25

3. Simultaneously both expression of LMP-1 and methylation of E-cadherin: Molecular biomarker in stage IV of nasopharyngeal carcinoma patients;Balkan Journal of Medical Genetics;2021-06-01

4. Association BetweenLMP-1,LMP-2, and miR-155 Expression as Potential Biomarker in Nasopharyngeal Carcinoma Patients: A Case/Control Study in Vietnam;Genetic Testing and Molecular Biomarkers;2019-11-01

5. ATR activated by EB virus facilitates chemotherapy resistance to cisplatin or 5-fluorouracil in human nasopharyngeal carcinoma;Cancer Management and Research;2019-01